ערך בספרים למניה: nephros.com (NEPH)

Nephros, Inc. develops US-based plants for the creation of water purification systems for clinics. The total book value visualized on the chart reflects the stability of production cycles and assembly automation. Strict US medical regulations and high customer switching costs generate sustainable revenue. Robotic lines eliminate membrane defects, although the development of new filters remains the responsibility of scientists. The value of 1.11 characterizes this valuation parameter.

The limited scale of ultrafiltration system implementation in clinics is constraining the operating leverage of Nephros, Inc. (NEPH), which is reflected in the net asset accumulation trend. By analyzing the current book value per share, the investor assesses the company's residual value minus liabilities per share, utilizing this fundamental indicator to filter out market noise and determine the actual reliability of the investment.